Amtagvi Suspension
Product Images NDC 73776-001

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Amtagvi (NDC 73776-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Iovance Biotherapeutics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (125 mL Bag Cartridge Label)

Label for AMTAGVI (lifileucel) human T-cells suspension for intravenous infusion by Iovance Biotherapeutics Inc. Includes dosage instructions, storage conditions, contents, lot and expiry details, recipient information fields, and company contact details. Product NDC 73776-001.*

FDA Label Image

Lifileucel-02 (Lifileucel 02)

Label for AMTAGVI (lifileucel) human T-cells suspension for intravenous infusion. The label includes dosage volume per bag (100-125 mL), cell content, storage instructions requiring vapor phase liquid nitrogen, and thawing conditions. It shows the NDC 73776-001-12, manufacturer Advanced Therapies, LLC, and labeler Iovance Biotherapeutics Inc. Patient and product batch details with QR codes are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.